The novel therapy of this peptide represents a significant development in the handling of diabetes mellitus type 2. Unlike existing medications, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide094734.bloguerosa.com/40642539/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment